Nuvama's Pharma Power Picks: 7 Stocks Poised for Major Gains You Can't Afford to Miss!

Overview

Brokerage firm Nuvama has identified seven top stock picks in the Indian pharma sector, expecting them to lead the next growth cycle. These companies showed strong Q2 FY26 performance with double-digit revenue and profit growth. Nuvama highlights potential upsides ranging from 11.5% to over 33% for these selected companies, focusing on domestic formulations and CDMO businesses.